| 标题 |
Insights into vepdegestrant (ARV-471): The first-in-class estrogen receptor proteolysis-targeting chimera approaching Food and Drug Administration approval for breast cancer
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Chao Tang, Bin Tian, Bingxing Zhang, Yunfei Zhang, Changhua Ke, Mengxin Chen, Meiyan Wei, Wen Wang, Xintao Deng, Qiannan Zhang, Mengzhou Wang, Juan Xia, Meiling He, Chengyuan Liang*, Lei Tian*. Insights into vepdegestrant (ARV-471): The first-in-class estrogen receptor proteolysis-targeting chimera approaching Food and Drug Administration approval for breast cancer. ChemMedChem, 2026, 21(6): e202501111. |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
cat
Kao
aajhajkahna
Criminology34
Nole
GingerF
张欢馨
OK
dde
huanhuanhuan
ming2026
东方元语
小小牛马
Nexus
vampv
sagitar
大刘
渡人舟
松2026
皖公网安备34019202002308
